[{"data":1,"prerenderedAt":492},["ShallowReactive",2],{"blog-post-the-best-ai-tools-for-drug-discovery":3,"blog-posts-nav":22},{"data":4,"meta":18},[5],{"id":6,"attributes":7},78,{"title":8,"content":9,"createdAt":10,"updatedAt":11,"publishedAt":12,"date":13,"description":14,"keywords":15,"slug":16,"category":17},"The best AI tools for drug discovery","The best AI tools for drug discovery are a stack of specialized models: [AlphaFold 3](https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fs41586-024-07487-w) and [Boltz-2](https:\u002F\u002Fgithub.com\u002Fjwohlwend\u002Fboltz) for structure prediction, RFdiffusion3 (beta) and ProteinMPNN for de novo design, docking engines, ADMET predictors, and generative chemistry. Nanome ties them together through [MARA](https:\u002F\u002Fnanome.ai\u002Fmara), an AI copilot that runs these tools from plain-English requests, shows you exactly what ran, and deploys behind your firewall.\n\nNo single model carries a project on its own, so the work runs as a chain: fold, dock, score, filter, repeat. Five categories cover most of it, and each one has more than one credible engine behind it.\n\n## Five categories, and what runs in each\n\n\u003Cdiv class=\"logo-row\" style=\"display:flex;flex-wrap:wrap;align-items:center;justify-content:center;gap:1.75rem;background:#fff;border-radius:12px;padding:1.25rem 1.5rem;margin:2rem 0\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fthe_best_ai_tools_for_drug_discovery_image_4_1cfcbd4a28.png\" alt='AlphaFold 3' style=\"width:120px;height:44px;object-fit:contain;display:inline-block\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fthe_best_ai_tools_for_drug_discovery_image_6_8ce14dce4b.png\" alt='ProteinMPNN' style=\"width:120px;height:44px;object-fit:contain;display:inline-block\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fthe_best_ai_tools_for_drug_discovery_image_8_edc7494425.png\" alt='OpenEye' style=\"width:120px;height:44px;object-fit:contain;display:inline-block\">\u003Cimg src=\"https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fthe_best_ai_tools_for_drug_discovery_image_9_2f21ccfe28.png\" alt='MOE' style=\"width:120px;height:44px;object-fit:contain;display:inline-block\">\u003C\u002Fdiv>\n\n\n\n**Structure prediction.** A sequence goes in, a 3D fold comes out. AlphaFold 3 is DeepMind's current public model, and Boltz-2 is one of several open engines that co-fold a protein together with its ligand. OpenFold3, Chai-1, ESMFold and Protenix cover similar ground with different tradeoffs, which is why running two of them and comparing the answers is ordinary practice.\n\n**De novo design.** RFdiffusion3 draws protein backbones that don't exist yet, all-atom, with inference roughly 10 times faster than the generation before it. ProteinMPNN then writes a sequence that should fold into that shape. Between them you get a binder for a target no database has an answer for.\n\n**Docking.** A protein and a small molecule go in, and the engine predicts the pose and scores the fit. Smina and DiffDock-L are the two engines MARA calls for this. Docking is cheap and noisy enough that the working unit is hundreds of runs.\n\n**ADMET.** Absorption, distribution, metabolism, excretion, toxicity. A compound that binds beautifully and then fails on toxicity has already burned real time and money, so these predictors sit early in the funnel. eToxPred and ToxinPred handle the toxicity half.\n\n**Generative chemistry.** The model proposes molecules against a target, scores them, and takes the survivors round again. Cheminformatics routines do the bookkeeping around that loop: similarity, properties, filtering, and the record of what got proposed when.\n\nStringing those calls into one long autonomous run raises its own questions, and [agentic AI for computational chemistry](https:\u002F\u002Fnanome.ai\u002Fblog\u002Fagentic-ai-for-computational-chemistry) works through them.\n\n## Comparison\n\n\u003Ctable class=\"table\">\n  \u003Cthead>\n    \u003Ctr>\u003Cth>Model or category\u003C\u002Fth>\u003Cth>What it does well\u003C\u002Fth>\u003Cth>What Nanome and MARA add\u003C\u002Fth>\u003C\u002Ftr>\n  \u003C\u002Fthead>\n  \u003Ctbody>\n    \u003Ctr>\u003Ctd>AlphaFold 3, Boltz-2\u003C\u002Ftd>\u003Ctd>Structure and complex prediction\u003C\u002Ftd>\u003Ctd>MARA calls either engine and colors the result by confidence; Nanome loads it in 3D\u003C\u002Ftd>\u003C\u002Ftr>\n    \u003Ctr>\u003Ctd>RFdiffusion3 (beta)\u003C\u002Ftd>\u003Ctd>De novo protein backbone generation\u003C\u002Ftd>\u003Ctd>MARA chains backbone, sequence and fold check from one request\u003C\u002Ftd>\u003C\u002Ftr>\n    \u003Ctr>\u003Ctd>ProteinMPNN, ANARCI\u003C\u002Ftd>\u003Ctd>Sequence design; antibody numbering and CDR definition\u003C\u002Ftd>\u003Ctd>MARA runs both across an antibody campaign\u003C\u002Ftd>\u003C\u002Ftr>\n    \u003Ctr>\u003Ctd>Smina, DiffDock-L\u003C\u002Ftd>\u003Ctd>Pose prediction for hits\u003C\u002Ftd>\u003Ctd>MARA docks and ranks; Nanome puts the top poses in front of the team at any scale\u003C\u002Ftd>\u003C\u002Ftr>\n    \u003Ctr>\u003Ctd>APBS\u003C\u002Ftd>\u003Ctd>Electrostatics\u003C\u002Ftd>\u003Ctd>MARA solves the field and Nanome paints it onto the surface\u003C\u002Ftd>\u003C\u002Ftr>\n    \u003Ctr>\u003Ctd>ADMET and toxicity models\u003C\u002Ftd>\u003Ctd>Filtering on druglikeness and tox risk\u003C\u002Ftd>\u003Ctd>MARA scores a series before anyone commits it to synthesis\u003C\u002Ftd>\u003C\u002Ftr>\n    \u003Ctr>\u003Ctd>\u003Ca href=\"https:\u002F\u002Fwww.schrodinger.com\">Schrödinger\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fwww.eyesopen.com\">OpenEye\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fwww.chemcomp.com\">CCG MOE\u003C\u002Fa>\u003C\u002Ftd>\u003Ctd>Full comp-chem suites\u003C\u002Ftd>\u003Ctd>Nanome integrates with all three and adds a shared 3D room on top\u003C\u002Ftd>\u003C\u002Ftr>\n  \u003C\u002Ftbody>\n\u003C\u002Ftable>\n\n## Where Nanome and MARA fit\n\n![A plain-English request flows into a central hub that fans out to four specialized scientific tool icons, with a transparency log below.](https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fthe_best_ai_tools_for_drug_discovery_image_2_205a49f2dc.png)\n\n\n\nNanome is a collaborative molecular visualization and drug discovery platform. It runs in [the browser, on Windows, and in XR on Meta Quest, Vive Focus 3, Pico Neo and Apple Vision Pro](https:\u002F\u002Fnanome.ai\u002Fsetup). Structures arrive by accession code from RCSB PDB, PubChem or DrugBank, or straight off a disk as PDB or SDF.\n\nNanome's copilot, MARA, reaches [300+ integrated scientific tools across 26 categories](https:\u002F\u002Fnanome.ai\u002Fintegrations). It runs [docking, co-folding, electrostatics and ADMET prediction](https:\u002F\u002Fnanome.ai\u002Fagents), numbers antibody variable domains and marks their CDR loops with ANARCI, designs sequences with ProteinMPNN, generates backbones with RFdiffusion3, and predicts folds with Boltz-2 or AlphaFold 3.\n\nGroups add their own code to that library. An in-house script, or a model a team trained on its own data, becomes a MARA tool that anyone in the org can then call by name in a sentence.\n\nA request in plain English is enough. MARA picks the tool, runs it, and hands back a record: which tool fired, the inputs it took, the artifact it produced. When a colleague or a regulator wants to know where a number came from, that record is the answer. The day-to-day rhythm of working this way gets a fuller walkthrough in [an AI copilot for drug discovery workflows](https:\u002F\u002Fnanome.ai\u002Fblog\u002Fan-ai-copilot-for-drug-discovery-workflows).\n\nTwo properties of the setup carry most of the weight. Several people share one 3D session and study the same binding pocket at the same moment, in the browser or in a headset. And enterprise installs of Nanome and MARA sit inside your own network, as a single tenant in the cloud or on hardware you run, so an unpublished target stays where it started.\n\nInsilico Medicine worked exactly that way on COVID-19. Their AI generated 10 novel SARS-CoV-2 protease inhibitors, and the medicinal chemists reviewed those molecules in Nanome in VR before the program went any further. The work was co-authored and posted to ChemRxiv. Insilico's CEO gave the reasoning:\n\n> \"While AI can come up with novel and diverse drug-like molecules, it is important for medicinal chemists to look at these molecules closely before placing a billion-dollar, life-or-death wager. VR enables medicinal chemists to do this.\"\n>\n> Alex Zhavoronkov, CEO, Insilico Medicine\n\nThe peer-reviewed record behind the platform is under [publications](https:\u002F\u002Fnanome.ai\u002Fpublications).\n\n## When to run the model directly\n\n![Two colleagues in a bright research lounge examine a protein-ligand surface model on a large display, one pointing at the binding pocket.](https:\u002F\u002Fnanome-cms.s3.us-west-1.amazonaws.com\u002Fthe_best_ai_tools_for_drug_discovery_image_3_348c9e5eef.png)\n\n\n\nOne model at volume belongs on a queue. Folding 10,000 sequences overnight, with nothing to visualize and nobody watching, is a job for AlphaFold 3 in a script, and a graphical interface adds nothing to it.\n\nWhen the deep work of a project lives in [Schrödinger Maestro](https:\u002F\u002Fwww.schrodinger.com\u002Fplatform\u002Fproducts\u002Fmaestro\u002F), MOE or [BIOVIA Discovery Studio](https:\u002F\u002Fwww.3ds.com\u002Fproducts\u002Fbiovia\u002Fdiscovery-studio), that is where it should stay. Nanome opens Maestro `.mae` and `.maegz` (the format LiveDesign hands over) and `.moe` files for viewing, and it parses the ordinary PDB, mmCIF, SDF, MOL\u002FMOL2, XYZ and PQR a pipeline already writes. Molecules come back out as PDB, SDF or SMILES, one frame at a time. [More on supported formats](https:\u002F\u002Fdocs.nanome.ai\u002Fnanome_web\u002Ffileformats).\n\nNanome connects to [CDD Vault](https:\u002F\u002Fwww.collaborativedrug.com), Cresset Flare, OpenEye (Cadence) and Schrödinger LiveDesign over an open REST API and MCP servers, so the output of a run lands next to the assay record it belongs with. What other groups have built on that footing is at [nanome.ai\u002Fcase-studies](https:\u002F\u002Fnanome.ai\u002Fcase-studies).\n\n## FAQ\n\n**What are the best AI tools for drug discovery?**\nStructure prediction runs on AlphaFold 3 and Boltz-2, with OpenFold3, Chai-1, ESMFold and Protenix alongside them. De novo design runs on RFdiffusion3 and ProteinMPNN. Docking runs on Smina and DiffDock-L, and ADMET plus toxicity models filter what survives. Nanome's MARA copilot reaches 300+ of these across 26 categories and drives them from a sentence.\n\n**What are AI-powered molecular analysis tools?**\nSoftware that predicts, generates or scores molecular structure with machine learning: folding models, binder generators, docking engines, electrostatics solvers and ADMET predictors. MARA runs them, and Nanome loads what comes back into a 3D workspace a whole team can join.\n\n**Can I run these models without writing code?**\nYes. A request in ordinary English is enough. MARA selects the tool, runs it, and reports what went in and what came out, and the structures it produced land in the Nanome workspace ready to turn over.\n\n**Is my data safe with an AI copilot?**\nEnterprise deployments of Nanome and MARA sit inside your own network, as a single-tenant cloud instance or fully on-premises. Structures, sequences and the prompts you type stay in the environment they started in.\n","2026-07-15T01:23:49.712Z","2026-09-17T16:00:08.446Z","2026-09-17T16:00:08.403Z","2026-09-17","The best AI tools for drug discovery, by category, plus how Nanome and MARA run them in plain English.","best AI tools for drug discovery, AI-powered molecular analysis tools, AlphaFold, Boltz-2, RFdiffusion, ProteinMPNN, ADMET prediction, MARA, Nanome","the-best-ai-tools-for-drug-discovery","frequent-topics",{"pagination":19},{"page":20,"pageSize":21,"pageCount":20,"total":20},1,100,{"data":23,"meta":490},[24,29,35,40,45,50,55,60,65,70,75,81,86,91,97,102,107,112,117,122,127,132,137,142,147,153,158,163,168,173,178,183,188,193,198,203,208,213,218,223,228,233,238,243,248,253,258,263,268,273,278,283,288,293,298,303,309,314,319,324,329,334,339,344,349,354,359,364,369,374,379,384,389,394,399,404,409,414,419,424,429,434,439,444,449,454,459,464,469,474,478,483,488],{"id":20,"attributes":25},{"slug":26,"title":27,"category":28},"spy-stories-and-rational-drug-design","Spy stories & rational drug design","case-studies",{"id":30,"attributes":31},2,{"slug":32,"title":33,"category":34},"meta-quest-pro-and-a-new-version-of-nanome-(v1.24)","Meta Quest Pro & a new version of Nanome (v1.24)","releases",{"id":36,"attributes":37},3,{"slug":38,"title":39,"category":28},"beating-the-pandemic-in-virtual-reality","Beating the Pandemic in Virtual Reality",{"id":41,"attributes":42},4,{"slug":43,"title":44,"category":28},"a-new-era-in-drug-discovery-the-first-ai-generated-drug-is-going-to-clinical-trial","A new era in drug discovery? The first AI-generated drug is going to clinical trial",{"id":46,"attributes":47},5,{"slug":48,"title":49,"category":28},"antibody-prophylaxis-for-lyme-disease","Antibody Prophylaxis for Lyme Disease",{"id":51,"attributes":52},6,{"slug":53,"title":54,"category":28},"diabetes-treatment-is-about-to-change-forever","Diabetes treatment is about to change forever",{"id":56,"attributes":57},7,{"slug":58,"title":59,"category":34},"april-2023-nanome-plugins-and-home.nanome.ai-updates","April 2023 Nanome Plugins & home.nanome.ai Updates",{"id":61,"attributes":62},8,{"slug":63,"title":64,"category":34},"v1.24.4-patch-release-blog-and-data-table-plugin-update","v1.24.4 Patch Release Blog and Data Table Plugin Update",{"id":66,"attributes":67},9,{"slug":68,"title":69,"category":28},"exploring-gaba-in-vr-common-therapeutics-can-reverse-pathological-sleep-conditions","Exploring GABA in VR - Common therapeutics can reverse pathological sleep conditions",{"id":71,"attributes":72},10,{"slug":73,"title":74,"category":34},"introducing-mara:-a-paradigm-shift-in-ai-assisted-scientific-informatics-workflow-orchestration","Introducing MARA: A Paradigm Shift in AI-assisted Scientific Informatics Workflow Orchestration",{"id":76,"attributes":77},11,{"slug":78,"title":79,"category":80},"reflecting-on-2023-and-looking-forward-to-2024","Reflecting on 2023, and looking forward to 2024","philosophy",{"id":82,"attributes":83},12,{"slug":84,"title":85,"category":80},"our-thoughts-on-the-up-and-coming-apple-vision-pro","Our thoughts on the up & coming Apple Vision Pro ",{"id":87,"attributes":88},14,{"slug":89,"title":90,"category":34},"introducing-the-the-nanome-scene-viewer-plugin","Introducing the The Nanome Scene Viewer Plugin",{"id":92,"attributes":93},13,{"slug":94,"title":95,"category":96},"revolutionize-your-research-with-the-nanome-jupyter-cookbook-plugin","Revolutionize Your Research with the Nanome Jupyter Cookbook Plugin","tutorials",{"id":98,"attributes":99},15,{"slug":100,"title":101,"category":80},"nanospin:-a-glimpse-into-nanome's-vision-for-the-future-with-apple-vision-pro","NanoSpin: A Glimpse into Nanome's Vision for the Future with Apple Vision Pro",{"id":103,"attributes":104},16,{"slug":105,"title":106,"category":34},"calcflow-comes-to-the-apple-vision-pro","Calcflow comes to the Apple Vision Pro",{"id":108,"attributes":109},17,{"slug":110,"title":111,"category":34},"nanome-apple-vision-pro-and-2.0-dev-blog-april-2024","Nanome Apple Vision Pro & 2.0 Dev Blog April 2024",{"id":113,"attributes":114},18,{"slug":115,"title":116,"category":34},"mara-q2-2024-update-blog","MARA Q2 2024 Update Blog",{"id":118,"attributes":119},19,{"slug":120,"title":121,"category":80},"nanome-on-apple-vision-pro-roadmap","Nanome on Apple Vision Pro Roadmap",{"id":123,"attributes":124},20,{"slug":125,"title":126,"category":34},"v1.24.6-patch-release","v1.24.6 Patch Release",{"id":128,"attributes":129},21,{"slug":130,"title":131,"category":34},"mara-public-beta-coming-soon","MARA Public Beta Coming Soon ",{"id":133,"attributes":134},22,{"slug":135,"title":136,"category":34},"introduction-to-mara-freemium","Introduction to MARA Freemium",{"id":138,"attributes":139},23,{"slug":140,"title":141,"category":96},"computer-aided-drug-discovery-and-design-through-mara","Computer-Aided Drug Discovery & Design through MARA",{"id":143,"attributes":144},24,{"slug":145,"title":146,"category":96},"mara-and-cdd-integration-example","MARA & CDD Integration Example",{"id":148,"attributes":149},26,{"slug":150,"title":151,"category":152},"collaborative-drug-discovery-and-nanome-partnership-announcement","Collaborative Drug Discovery & Nanome Partnership Announcement","partnerships",{"id":154,"attributes":155},25,{"slug":156,"title":157,"category":96},"introduction-to-mara-tool-creation","Introduction to MARA Tool Creation",{"id":159,"attributes":160},27,{"slug":161,"title":162,"category":34},"mara-update:-v0.12.10","MARA Update: v0.12.10",{"id":164,"attributes":165},28,{"slug":166,"title":167,"category":96},"mara-bioinformatics-workflow","MARA Bioinformatics Workflow",{"id":169,"attributes":170},29,{"slug":171,"title":172,"category":96},"mara-cheminformatics-workflow","MARA Cheminformatics Workflow",{"id":174,"attributes":175},32,{"slug":176,"title":177,"category":34},"announcing-the-early-access-program-for-nanome-ai:-the-next-generation-of-molecular-design","Announcing the Early Access Program for Nanome AI: The Next Generation of Molecular Design",{"id":179,"attributes":180},31,{"slug":181,"title":182,"category":96},"mara-and-jupyter-notebook-integration","MARA and Jupyter Notebook Integration",{"id":184,"attributes":185},33,{"slug":186,"title":187,"category":96},"exploring-the-new-scene-menu-in-nanome-2.0:-a-comprehensive-guide","Exploring the New Scene Menu in Nanome 2.0: A Comprehensive Guide",{"id":189,"attributes":190},34,{"slug":191,"title":192,"category":96},"understanding-nanome-2.0's-new-permissioning-system:-a-guide-to-secure-and-collaborative-workspaces","Understanding Nanome 2.0’s New Permissioning System: A Guide to Secure and Collaborative Workspaces",{"id":194,"attributes":195},35,{"slug":196,"title":197,"category":96},"nanome-2.0:-a-deep-dive-into-the-technical-foundations","Nanome 2.0: A Deep Dive into the Technical Foundations",{"id":199,"attributes":200},36,{"slug":201,"title":202,"category":34},"major-updates-to-the-nanome-documentation-site","Major Updates to the Nanome Documentation Site",{"id":204,"attributes":205},37,{"slug":206,"title":207,"category":96},"assay-data-enabled-analysis-workflows-in-mara","Assay Data Enabled Analysis Workflows in MARA",{"id":209,"attributes":210},38,{"slug":211,"title":212,"category":96},"from-vault-to-workspaces:-the-evolution-of-file-and-workflow-management-in-nanome-2.0","From Vault to Workspaces: The Evolution of File and Workflow Management in Nanome 2.0",{"id":214,"attributes":215},39,{"slug":216,"title":217,"category":80},"looking-back-at-2024-and-what's-next-for-nanome-in-2025","Looking Back at 2024 and What’s Next for Nanome in 2025",{"id":219,"attributes":220},40,{"slug":221,"title":222,"category":96},"how-nanome's-agentic-platform-can-enhance-and-integrate-with-your-docking-and-structural-visualization-workflows","How Nanome’s agentic platform can enhance and integrate with your docking and structural visualization workflows",{"id":224,"attributes":225},41,{"slug":226,"title":227,"category":34},"nanome-ai-february-2025-update!","Nanome AI February 2025 Update!",{"id":229,"attributes":230},42,{"slug":231,"title":232,"category":34},"mara's-updated-workflow-processes-provide-huge-time-savings!","MARA’s Updated Workflow Processes Provide Huge Time Savings!",{"id":234,"attributes":235},43,{"slug":236,"title":237,"category":152},"livedesign-live-reports-literally-at-your-fingertips","LiveDesign Live Reports — Literally at Your Fingertips",{"id":239,"attributes":240},44,{"slug":241,"title":242,"category":34},"nanome-v2.1.0-release-update:-new-workspace-api-interactions-alignment-ligands-table-and-more!","Nanome v2.1.0 Release Update: New Workspace API, Interactions, Alignment, Ligands Table, and more!",{"id":244,"attributes":245},45,{"slug":246,"title":247,"category":152},"view-your-openeyecadence-data-with-fresh-eyes-using-nanome-xr","View Your OpenEye\u002FCadence Data with Fresh Eyes using Nanome XR",{"id":249,"attributes":250},46,{"slug":251,"title":252,"category":34},"nanome-v2.1.1-patch-release-update:-new-scene-pov-sdf-metadata-support-and-rendering-improvements","Nanome v2.1.1 Patch Release Update: New Scene POV, SDF Metadata Support, and Rendering Improvements",{"id":254,"attributes":255},47,{"slug":256,"title":257,"category":34},"nanome-v2.2.0:-measure-interact-and-analyze-from-atom-to-angstroms","Nanome v2.2.0: Measure, Interact, and Analyze from Atom to Angstroms",{"id":259,"attributes":260},48,{"slug":261,"title":262,"category":28},"v2.2-usecase-blog:-how-a-biochemist-leveraged-measurement-tools-in-xr-to-streamline-protein-design","V2.2 Usecase Blog: How a biochemist leveraged Measurement Tools in XR to Streamline Protein Design",{"id":264,"attributes":265},49,{"slug":266,"title":267,"category":152},"from-pdb-to-pose:-integration-of-nanome's-mara-and-cresset's-flare","From PDB to Pose: Integration of Nanome’s MARA and Cresset’s Flare",{"id":269,"attributes":270},50,{"slug":271,"title":272,"category":34},"nanome-v2.3.0:-new-tools-(builder-and-selection)-sequence-menu-and-web-preview","Nanome V2.3.0: New Tools (Builder and Selection), Sequence Menu, and Web Preview",{"id":274,"attributes":275},51,{"slug":276,"title":277,"category":34},"important-security-update-for-nanome-unity-vulnerability-patch","Important Security Update for Nanome – Unity Vulnerability Patch",{"id":279,"attributes":280},52,{"slug":281,"title":282,"category":80},"interface-to-design-the-future","Interface to Design the Future",{"id":284,"attributes":285},53,{"slug":286,"title":287,"category":96},"setting-up-boltz-2-configuration-files-and-analysis-with-nanome-ai","Setting Up Boltz-2 Configuration Files and Analysis with Nanome AI",{"id":289,"attributes":290},54,{"slug":291,"title":292,"category":152},"meta-horizon-managed-services-goes-free:-what-this-means-for-enterprise-vr-users","Meta Horizon Managed Services Goes Free: What This Means for Enterprise VR Users",{"id":294,"attributes":295},55,{"slug":296,"title":297,"category":34},"nanome-v2.4.0:-early-access-release-mara-voice-commands-minimization-chem-interactions-and-more!","Nanome v2.4.0: Early Access Release, Mara Voice Commands, Minimization, Chem Interactions, and more! ",{"id":299,"attributes":300},60,{"slug":301,"title":302,"category":152},"nanome-joins-the-openfold-consortium","Nanome Joins the OpenFold Consortium",{"id":304,"attributes":305},66,{"slug":306,"title":307,"category":308},"announcing:-nanome-claude-code-skill-and-mcp-server-and-what's-next-for-mara","Announcing: Nanome Claude Code Skill & MCP Server, and What's Next for MARA",null,{"id":310,"attributes":311},69,{"slug":312,"title":313,"category":80},"the-new-front-door-to-nanome","The New Front Door to Nanome",{"id":315,"attributes":316},68,{"slug":317,"title":318,"category":34},"nanome-v2.5:-web-trajectories-torsion-tool-and-more","Nanome v2.5: Web, Trajectories, Torsion Tool, and More",{"id":320,"attributes":321},70,{"slug":322,"title":323,"category":308},"academic-license-update-for-nanome","Academic License Update for Nanome",{"id":325,"attributes":326},71,{"slug":327,"title":328,"category":34},"web-app-1.0-ships-today-and-mara's-beta-tag-comes-off-with-it.","Web App 1.0 ships today, and MARA's beta tag comes off with it.",{"id":330,"attributes":331},138,{"slug":332,"title":333,"category":34},"v2.6-release-blog:-scene-recording-residue-editor-mara-tools-in-xr-and-more","V2.6 Release Blog: Scene Recording, Residue Editor, MARA Tools in XR, and More",{"id":335,"attributes":336},140,{"slug":337,"title":338,"category":28},"how-resonac-turned-two-years-of-misaligned-randd-into-a-single-afternoon-breakthrough","How Resonac Turned Two Years of Misaligned R&D Into a Single Afternoon Breakthrough",{"id":340,"attributes":341},141,{"slug":342,"title":343,"category":308},"nanome-mcp-is-live!","Nanome MCP is live!",{"id":345,"attributes":346},142,{"slug":347,"title":348,"category":17},"what-a-modern-molecular-presentation-looks-like","The molecular PowerPoint: what a modern molecular presentation looks like",{"id":350,"attributes":351},83,{"slug":352,"title":353,"category":17},"collaborative-drug-discovery-software-for-remote-teams","Collaborative drug discovery software for remote teams",{"id":355,"attributes":356},103,{"slug":357,"title":358,"category":17},"vr-for-medicinal-chemists","VR for medicinal chemists",{"id":360,"attributes":361},85,{"slug":362,"title":363,"category":17},"how-to-analyze-protein-ligand-interactions","How to analyze protein-ligand interactions",{"id":365,"attributes":366},86,{"slug":367,"title":368,"category":17},"how-to-visualize-proteins-in-vr","How to visualize proteins in VR",{"id":370,"attributes":371},102,{"slug":372,"title":373,"category":17},"how-to-view-pdb-files-in-3d-and-the-tools-that-do-it-well","How to view PDB files in 3D, and the tools that do it well",{"id":375,"attributes":376},90,{"slug":377,"title":378,"category":17},"molecular-visualization-for-structural-biologists","Molecular visualization for structural biologists",{"id":380,"attributes":381},77,{"slug":382,"title":383,"category":17},"software-for-computational-antibody-design","Software for computational antibody design",{"id":385,"attributes":386},84,{"slug":387,"title":388,"category":17},"drug-discovery-software-for-computational-chemistry","Drug discovery software for computational chemistry",{"id":390,"attributes":391},105,{"slug":392,"title":393,"category":17},"the-best-molecular-visualization-tools","The best molecular visualization tools",{"id":395,"attributes":396},88,{"slug":397,"title":398,"category":17},"software-for-molecular-docking-visualization","Software for molecular docking visualization",{"id":400,"attributes":401},87,{"slug":402,"title":403,"category":17},"mcp-servers-for-cheminformatics-and-drug-discovery","MCP servers for cheminformatics and drug discovery",{"id":405,"attributes":406},74,{"slug":407,"title":408,"category":17},"agentic-ai-for-computational-chemistry","Agentic AI for computational chemistry",{"id":410,"attributes":411},75,{"slug":412,"title":413,"category":17},"an-ai-copilot-for-drug-discovery-workflows","An AI copilot for drug discovery workflows",{"id":415,"attributes":416},94,{"slug":417,"title":418,"category":17},"how-nanome-is-different-from-pymol","How Nanome is different from PyMOL",{"id":420,"attributes":421},93,{"slug":422,"title":423,"category":17},"how-nanome-is-different-from-moe","How Nanome is different from MOE",{"id":425,"attributes":426},92,{"slug":427,"title":428,"category":17},"how-nanome-is-different-from-biovia-discovery-studio","How Nanome is different from BIOVIA Discovery Studio",{"id":430,"attributes":431},95,{"slug":432,"title":433,"category":17},"how-nanome-is-different-from-schrodinger-maestro","How Nanome is different from Schrödinger Maestro",{"id":435,"attributes":436},98,{"slug":437,"title":438,"category":17},"tools-for-visualizing-protein-ligand-interactions","Tools for visualizing protein-ligand interactions",{"id":440,"attributes":441},96,{"slug":442,"title":443,"category":17},"how-nanome-is-different-from-vmd","How Nanome is different from VMD",{"id":445,"attributes":446},145,{"slug":447,"title":448,"category":17},"how-to-run-an-sar-meeting","How to run an SAR meeting on a 3D structure",{"id":450,"attributes":451},91,{"slug":452,"title":453,"category":17},"how-nanome-is-different-from-ucsf-chimerax","How Nanome is different from UCSF ChimeraX",{"id":455,"attributes":456},97,{"slug":457,"title":458,"category":17},"natural-language-interfaces-for-molecular-modeling","Natural language interfaces for molecular modeling",{"id":460,"attributes":461},89,{"slug":462,"title":463,"category":17},"software-for-visualizing-molecular-dynamics-trajectories","Software for visualizing molecular dynamics trajectories",{"id":465,"attributes":466},144,{"slug":467,"title":468,"category":17},"presenting-computational-results-to-experimental-teams","How to present computational results to an experimental team",{"id":470,"attributes":471},143,{"slug":472,"title":473,"category":17},"how-to-share-a-3d-molecular-structure-with-your-team","How to share a 3D molecular structure with your team",{"id":21,"attributes":475},{"slug":476,"title":477,"category":17},"spatial-computing-for-pharmaceutical-research","Spatial computing for pharmaceutical research",{"id":479,"attributes":480},76,{"slug":481,"title":482,"category":17},"running-alphafold-and-boltz-2-in-a-molecular-workflow","Running AlphaFold and Boltz-2 in a molecular workflow",{"id":484,"attributes":485},79,{"slug":486,"title":487,"category":17},"the-best-cheminformatics-tools-for-drug-discovery-teams","The best cheminformatics tools for drug discovery teams",{"id":6,"attributes":489},{"slug":16,"title":8,"category":17},{"pagination":491},{"page":20,"pageSize":21,"pageCount":20,"total":420},1789661277883]